{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:56:33Z","timestamp":1780322193201,"version":"3.54.1"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/01349"],"award-info":[{"award-number":["PI14\/01349"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI13\/01192"],"award-info":[{"award-number":["PI13\/01192"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0191805","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T18:47:34Z","timestamp":1517424454000},"page":"e0191805","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6037-1028","authenticated-orcid":true,"given":"Jos\u00e9 A.","family":"del Campo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Garc\u00eda-Valdecasas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gil-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Ampuero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Gallego-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Padillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Muntan\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Romero-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,1,31]]},"reference":[{"key":"ref1","article-title":"Hepatocellular Carcinoma in Cirrhosis: Incidence and Risk Factors","author":"G Fattovich","year":"2004","journal-title":"Gastroenterology"},{"key":"ref2","first-page":"1","article-title":"mTOR in Viral Hepatitis and Hepatocellular Carcinoma: Function and Treatment","volume":"2014","author":"Z Wang","year":"2014","journal-title":"Biomed Res Int"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4254\/wjh.v7.i1.70","article-title":"Surgical approach for hepatitis C virus-related hepatocellular carcinoma","volume":"7","author":"J Shindoh","year":"2015","journal-title":"World J Hepatol"},{"issue":"4","key":"ref4","first-page":"892","article-title":"Hepatitis C virus life cycle and lipid metabolism","volume":"3","author":"C-I Popescu","year":"2014","journal-title":"Biology (Basel)"},{"issue":"13","key":"ref5","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.1128\/JVI.00587-15","article-title":"Identification of Cholesterol 25-Hydroxylase as a Novel Host Restriction Factor and a Part of the Primary Innate Immune Responses against Hepatitis C Virus Infection","volume":"89","author":"Y Xiang","year":"2015","journal-title":"J Virol"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.4254\/wjh.v7.i8.1105","article-title":"Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin","volume":"7","author":"J Ampuero","year":"2015","journal-title":"World J Hepatol"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/hep.28506","article-title":"Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES","volume":"64","author":"TG Simon","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2012.10.005","article-title":"Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis","volume":"144","author":"S Singh","year":"2013","journal-title":"Gastroenterology"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.gastro.2004.12.049","article-title":"Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients","volume":"128","author":"M Romero-G\u00f3mez","year":"2005","journal-title":"Gastroenterology"},{"issue":"7506","key":"ref10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"AK Madiraju","year":"2014","journal-title":"Nature"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.26323","article-title":"The mTOR pathway in hepatic malignancies","volume":"58","author":"M Bhat","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.3892\/or.2013.2718","article-title":"Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1\/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo","volume":"30","author":"X CAI","year":"2013","journal-title":"Oncol Rep"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"e93256","DOI":"10.1371\/journal.pone.0093256","article-title":"AMP-Activated Protein Kinase Suppresses the In Vitro and In Vivo Proliferation of Hepatocellular Carcinoma","volume":"9","author":"J Cheng","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12985-015-0241-4","article-title":"Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner","volume":"12","author":"T Gao","year":"2015","journal-title":"Virol J"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/cdd.2008.18","article-title":"TCTP protects from apoptotic cell death by antagonizing bax function","volume":"15","author":"L Susini","year":"2008","journal-title":"Cell Death Differ"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.febslet.2010.11.014","article-title":"Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53","volume":"585","author":"SB Rho","year":"2011","journal-title":"FEBS Lett"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ctrv.2014.02.007","article-title":"TCTP as therapeutic target in cancers","volume":"40","author":"J Acunzo","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"ref18","first-page":"283","article-title":"Cytochrome P450 Protocols","author":"L Pichard","year":"2006"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"e70010","DOI":"10.1371\/journal.pone.0070010","article-title":"Metformin, a diabetes drug, eliminates tumor-initiating hepatocellular carcinoma cells","volume":"8","author":"T Saito","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1158\/1535-7163.MCT-14-0451","article-title":"Synergistic Simvastatin and Metformin Combination Chemotherapy for Osseous Metastatic Castration-Resistant Prostate Cancer","volume":"13","author":"MA Babcook","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"e1536","DOI":"10.1038\/cddis.2014.500","article-title":"Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells","volume":"5","author":"MA Babcook","year":"2014","journal-title":"Cell Death Dis"},{"issue":"19","key":"ref22","doi-asserted-by":"crossref","first-page":"e6888","DOI":"10.1097\/MD.0000000000006888","article-title":"Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients","volume":"96","author":"S Ma","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"e62823","DOI":"10.1371\/journal.pone.0062823","article-title":"Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT\/mTOR, ERK and JAK2\/STAT3 Pathway","volume":"8","author":"Z Fang","year":"2013","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1158\/1535-7163.MCT-06-0352","article-title":"Statins induce mammalian target of rapamycin (mTOR)-mediated inhibition of Akt signaling and sensitize p53-deficient cells to cytostatic drugs","volume":"5","author":"E Roudier","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/ijc.22519","article-title":"Regulation of P53 stability in p53 mutated human and mouse hepatoma cells","volume":"120","author":"S Hailfinger","year":"2007","journal-title":"Int J Cancer"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"MS Song","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/jcb.23000","article-title":"Metformin sensitizes insulin signaling through AMPK-mediated pten down-regulation in preadipocyte 3T3-L1 cells","volume":"112","author":"SK Lee","year":"2011","journal-title":"J Cell Biochem"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/hmg\/ddm364","article-title":"Regulation of the PTEN promoter by statins and SREBP","volume":"17","author":"RE Teresi","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"6","key":"ref29","first-page":"1593","article-title":"PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K\/Akt pathway","volume":"23","author":"T Tian","year":"2010","journal-title":"Oncol Rep"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bbrc.2012.03.066","article-title":"Down-regulated expression of the protein-tyrosine phosphatase 1B (PTP1B) is associated with aggressive clinicopathologic features and poor prognosis in hepatocellular carcinoma","volume":"420","author":"L-Y Zheng","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.canlet.2015.01.020","article-title":"PTP1B promotes cell proliferation and metastasis through activating src and ERK1\/2 in non-small cell lung cancer","volume":"359","author":"H Liu","year":"2015","journal-title":"Cancer Lett"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/hep.24709","article-title":"Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development","volume":"55","author":"THM Chan","year":"2012","journal-title":"Hepatology"},{"issue":"23","key":"ref33","doi-asserted-by":"crossref","first-page":"14976","DOI":"10.1073\/pnas.222470799","article-title":"Biological models and genes of tumor reversion: Cellular reprogramming through tpt1\/TCTP and SIAH-1","volume":"99","author":"M Tuynder","year":"2002","journal-title":"Proc Natl Acad Sci"},{"issue":"27","key":"ref34","doi-asserted-by":"crossref","first-page":"20870","DOI":"10.1074\/jbc.M110.112045","article-title":"Hepatitis C Virus NS5A Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Contributing to Cell Survival by Disrupting the Interaction between FK506-binding Protein 38 (FKBP38) and mTOR","volume":"285","author":"L Peng","year":"2010","journal-title":"J Biol Chem"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jhep.2013.04.012","article-title":"PTEN protein phosphatase activity regulates hepatitis C virus secretion through modulation of cholesterol metabolism","volume":"59","author":"M Peyrou","year":"2013","journal-title":"J Hepatol"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"e47904","DOI":"10.1371\/journal.pone.0047904","article-title":"The Hepatitis C Virus Modulates Insulin Signaling Pathway In Vitro Promoting Insulin Resistance","volume":"7","author":"JA Del Campo","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/525287","article-title":"Targeting Lipid Metabolism in the Treatment of Hepatitis C Virus Infection","volume":"197","author":"F Amemiya","year":"2008","journal-title":"J Infect Dis"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.22464","article-title":"Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response","volume":"48","author":"D Sir","year":"2008","journal-title":"Hepatology"},{"key":"ref39","first-page":"644","article-title":"Autophagy Protects Cells From HCV-Induced Defects in Lipid Metabolism","volume":"142","author":"T Vescovo","year":"2012","journal-title":"YGAST"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4161\/15548627.2014.984271","article-title":"Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway","volume":"11","author":"YM Song","year":"2015","journal-title":"Autophagy"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1007\/s13277-014-1676-8","article-title":"Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery","volume":"35","author":"M Aldea","year":"2014","journal-title":"Tumor Biol"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3727\/096504011X13021877989838","article-title":"Antidiabetic drug metformin induces apoptosis in human MCF breast cancer via targeting ERK signaling","volume":"19","author":"A Malki","year":"2011","journal-title":"Oncol Res"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/cdd.2012.113","article-title":"Induction of autophagy and senescence by knockdown of ROC1 E3 ubiquitin ligase to suppress the growth of liver cancer cells","volume":"20","author":"D Yang","year":"2013","journal-title":"Cell Death Differ"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jhep.2010.07.006","article-title":"Autophagy in liver diseases","volume":"53","author":"P-E Rautou","year":"2010","journal-title":"J Hepatol"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1475-2867-14-53","article-title":"Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis","volume":"14","author":"A Takahashi","year":"2014","journal-title":"Cancer Cell Int"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0191805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:08:28Z","timestamp":1589040508000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0191805"}},"subtitle":[],"editor":[{"given":"Matias A","family":"Avila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,31]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0191805","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,31]]}}}